The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

Exclusion Criteria

• •1. Any condition that prevents intravesical administration of medications.
• •2. Received medication or non-medication therapy, including physical therapy, for BPS/IC within 1 month prior to study inclusion.
• •3. Instillation of any pharmacological agent into the bladder less than 1 month prior to screening.
• •4. History of chronic drug or alcohol abuse.
• •5. Pregnant women, planning to become pregnant during the study, or currently breastfeeding.
• •6. Any other conditions associated with pelvic pain, except for PBS.
• •7. Pelvic surgery less than 6 months prior to the study.
• •8. Any intravesical procedures, except for diagnostic cystoscopy, less than 3 months prior to screening.
• •9. History of allergy or intolerance to the anesthetic or antibiotics that the investigator intends to use during the study.
• •10. Inability to discontinue anticoagulant/antiplatelet medications at least 5 days prior to each investigational drug administration and resume them on the 4th day after each investigational drug administration (low molecular weight heparin may be used for 3 days after investigational drug administration).
• •11. Diseases of the urinary tract/bladder (neoplasms, tuberculous and bacterial cystitis, urolithiasis, radiation injury, urethral diverticulum, neurogenic dysfunction of the lower urinary tract) and female genital organs (neoplasms, vaginitis, genital infections).
• •12. Other conditions that, in the opinion of the research physician, could become an objective obstacle to the patient's participation in the study and/or create additional risks for the patient.
• •13. A history of intravesical botulinum therapy performed within the last 12 months prior to inclusion in this study.
• •14. Bladder capacity under anesthesia less than 150 ml.
• •15. Residual urine volume greater than 50 ml.